financetom
Business
financetom
/
Business
/
HDFC claims default of 296 cr by Essel group's SITI Networks, moves NCLT
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
HDFC claims default of 296 cr by Essel group's SITI Networks, moves NCLT
Apr 15, 2022 12:06 PM

Housing Development Finance Corporation Ltd (HDFC) has moved insolvency tribunal NCLT against the country's leading multi-system operator SITI Networks Ltd for an alleged default of Rs 296 crore. SITI Networks has received a notice issued by the Mumbai bench of the National Company Law Tribunal over the petition filed by HDFCL, the Essel group firm said in a regulatory filing on Thursday.

Also Read:

HDFC Bank Jan-Mar earnings preview: Street expects net profit to increase 26% to Rs 10,347 crore

"The company has received the notice of the said case on April 13, 2022," the Essel group firm said adding it "is compiling information to verify the facts claimed in the said petition filed by HDFC." HDFC, in the petition filed under Section 7 of the Insolvency and Bankruptcy Code (IBC), has claimed a total default of Rs 296.06 crore, with respect to the financial facility provided by it.

"In the said petition filed under Section 7 of the Insolvency and Bankruptcy Code, 2016 read with Rule 4 of the Insolvency and Bankruptcy Rules, 2016, HDFC has allegedly claimed that the total amount in default with respect to the financial facility is Rs 296,06,48,008/- as on January 31, 2022," it said. Earlier on March 30, 2022, SITI Networks had informed the exchanges that it had been made aware about a petition filed before the NCLT by HDFC.

SITI Networks, formerly known as SITI Cable Network, is a part of the Essel Group. It provides its cable services in at 580 locations and adjoining areas, reaching out to over 11.3 million digital customers.

Also Read: Fitch Ratings foresee increased M&A prominence among banks post HDFC merger

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Solid Biosciences Signs Licensing Deal With Kinea Bio for AAV-SLB101 to Treat Muscular Dystrophy
Solid Biosciences Signs Licensing Deal With Kinea Bio for AAV-SLB101 to Treat Muscular Dystrophy
Sep 23, 2025
08:31 AM EDT, 09/23/2025 (MT Newswires) -- Solid Biosciences ( SLDB ) said Tuesday that it has signed a non-exclusive licensing and collaboration agreement with Kinea Bio to use Solid Biosciences' ( SLDB ) proprietary AAV-SLB101 to treat muscle tropism and reduced liver uptake. Under the terms of the deal, Solid has granted Kinea Bio a non-exclusive worldwide license to...
Connexi Expands Global Supply Chain Capabilities with Acquisition of Crown Agents Inspections Private Limited
Connexi Expands Global Supply Chain Capabilities with Acquisition of Crown Agents Inspections Private Limited
Sep 23, 2025
WASHINGTON and NEW DELHI, Sept. 23, 2025 /PRNewswire/ -- Connexi, Chemonics International's supply chain subsidiary, today announced the acquisition of Crown Agents Inspections Private Limited, or CA Inspections, a leading quality assurance and inspection services provider in India. The acquisition strengthens Connexi's ability to deliver end-to-end supply chain solutions, expanding its reach in Asia and enhancing its capacity for product...
Midland Exploration Starts Follow Up Program On Its New Discovery Of Gold-Zinc-Silver Mineralization at Caniapisc Au Project
Midland Exploration Starts Follow Up Program On Its New Discovery Of Gold-Zinc-Silver Mineralization at Caniapisc Au Project
Sep 23, 2025
09:29 AM EDT, 09/23/2025 (MT Newswires) -- Midland Exploration ( MIDLF ) announced Tuesday the start of a follow-up exploration program on its new discovery of gold, zinc, and silver on its Caniapisc Au project, in the Eeyou Istchee James Bay and Caniapiscau regions, and also announced map designation of two new projects in the same area. A statement noted...
Neurocrine Biosciences Says Ingrezza Shows Earlier Remission of Tardive Dyskinesia Symptoms
Neurocrine Biosciences Says Ingrezza Shows Earlier Remission of Tardive Dyskinesia Symptoms
Sep 23, 2025
09:29 AM EDT, 09/23/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Tuesday that a phase 4 open-label study confirmed robust rates of symptomatic remission of tardive dyskinesia with once-daily Ingrezza capsules. The analysis also showed sustained improvements in patient-reported outcomes among participants who achieved symptomatic remission, the company said. Shares of the company were down 1% in recent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved